Loss-of-function mutations in SCN1A have been observed in most cases of Dravet syndrome (DS), manifesting as epileptic seizures, hyperactivity, autistic traits, and cognitive decline. The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.